Moderna Looks To Catch Up In COVID-19 For Kids, While Still Branching Out In Other Areas
Biotech Teases Non-COVID Respiratory Programs
The company hopes to expand Spikevax’s reach beyond the current approved population while also looking to take the lead in mRNA vaccines in other diseases.
